Search
- Page Path
-
HOME
> Search
Review
- Structural Insights into the Lipopolysaccharide Transport (Lpt) System as a Novel Antibiotic Target.
-
Yurim Yoon, Saemee Song
-
J. Microbiol. 2024;62(4):261-275. Published online May 31, 2024
-
DOI: https://doi.org/10.1007/s12275-024-00137-w
-
-
Abstract
- Lipopolysaccharide (LPS) is a critical component of the extracellular leaflet within the bacterial outer membrane, forming an effective physical barrier against environmental threats in Gram-negative bacteria. After LPS is synthesized and matured in the bacterial cytoplasm and the inner membrane (IM), LPS is inserted into the outer membrane (OM) through the ATP-driven LPS transport (Lpt) pathway, which is an energy-intensive process. A trans-envelope complex that contains seven Lpt proteins (LptA-LptG) is crucial for extracting LPS from the IM and transporting it across the periplasm to the OM. The last step in LPS transport involves the mediation of the LptDE complex, facilitating the insertion of LPS into the outer leaflet of the OM. As the Lpt system plays an essential role in maintaining the impermeability of the OM via LPS decoration, the interactions between these interconnected subunits, which are meticulously regulated, may be potential targets for the development of new antibiotics to combat multidrug-resistant Gram-negative bacteria. In this review, we aimed to provide an overview of current research concerning the structural interactions within the Lpt system and their implications to clarify the function and regulation of LPS transport in the overall process of OM biogenesis.
Additionally, we explored studies on the development of therapeutic inhibitors of LPS transport, the factors that limit success, and future prospects.
Journal Articles
- miR-135b Aggravates Fusobacterium nucleatum-Induced Cisplatin Resistance in Colorectal Cancer by Targeting KLF13
-
Wei Zeng , Jia Pan , Guannan Ye
-
J. Microbiol. 2024;62(2):63-73. Published online February 24, 2024
-
DOI: https://doi.org/10.1007/s12275-023-00100-1
-
-
34
View
-
1
Download
-
3
Citations
-
Abstract
- Cisplatin resistance is the main cause of colorectal cancer (CRC) treatment failure, and the cause has been reported to be
related to Fusobacterium nucleatum (Fn) infection. In this study, we explored the role of Fn in regulating cisplatin resistance
of CRC cells and its underlying mechanism involved. The mRNA and protein expressions were examined by qRT-PCR
and western blot. Cell proliferation and cell apoptosis were assessed using CCK8 and flow cytometry assays, respectively.
Dual-luciferase reporter gene assay was adopted to analyze the molecular interactions. Herein, our results revealed that Fn
abundance and miR-135b expression were markedly elevated in CRC tissues, with a favorable association between the two.
Moreover, Fn infection could increase miR-135b expression via a concentration-dependent manner, and it also enhanced
cell proliferation but reduced apoptosis and cisplatin sensitivity by upregulating miR-135b. Moreover, KLF13 was proved
as a downstream target of miR-135b, of which overexpression greatly diminished the promoting effect of miR-135b or
Fn-mediated cisplatin resistance in CRC cells. In addition, it was observed that upstream 2.5 kb fragment of miR-135b
promoter could be interacted by β-catenin/TCF4 complex, which was proved as an effector signaling of Fn. LF3, a blocker
of β-catenin/TCF4 complex, was confirmed to diminish the promoting role of Fn on miR-135b expression. Thus, it could be
concluded that Fn activated miR-135b expression through TCF4/β-catenin complex, thereby inhibiting KLF13 expression
and promoting cisplatin resistance in CRC.
- Comparison of Conjunctival Sac Microbiome between Low and High Myopic Eyes
-
Kang Xiao , Zhengyu Chen , Qin Long
-
J. Microbiol. 2023;61(5):571-578. Published online April 21, 2023
-
DOI: https://doi.org/10.1007/s12275-023-00045-5
-
-
14
View
-
0
Download
-
1
Citations
-
Abstract
- Microbial communities played a vital role in maintaining homeostasis of ocular surface. However, no studies explored the
myopia-associated conjunctiva microbiota changes until now. In this study, conjunctival sac swab specimens were collected
from 12 eyes of low myopia (LM), and 14 eyes of high myopia (HM) patients. The V3–V4 region of the 16S rRNA gene was
amplified and then sequenced. Statistical analysis was performed to investigate differences in the taxonomy and diversity
between two groups. Compared to LM, higher Ocular Surface Disease Index (OSDI) scores were observed in HM group. The
Shannon index of the HM was lower than that of the LM group (P = 0.017). Principle coordinate analysis and Partial Least
Squares Discrimination Analysis showed distinct microbiome composition between two groups. At the phylum level, there
were higher relative abundances of Proteobacteria (68.27% vs 38.51%) and lower abundances of Actinobacteria (3.71% vs
9.19%) in HM, compared to LM group (P = 0.031, 0.010, respectively). At the genus level, the abundances of Acinetobacter
in HM (18.16%) were significantly higher than the LM (6.52%) group (P = 0.011). Actinobacteria levels were negatively
correlated with the myopic spherical equivalent and OSDI scores. Moreover, positive correlations were found between
Proteobacteria levels and OSDI scores, Acinetobacter levels were positively correlated with myopic spherical equivalent
and OSDI scores. In conclusion, HM Patients have bacterial microbiota imbalance in the conjunctival sac, compared with
LM patients. Proteobacteria, Actinobacteria, Acinetobacter may play roles in the HM associated ocular surface irritation.
Review
- Recent Advances in CRISPR‑Cas Technologies for Synthetic Biology
-
Song Hee Jeong , Ho Joung Lee , Sang Jun Lee
-
J. Microbiol. 2023;61(1):13-36. Published online February 1, 2023
-
DOI: https://doi.org/10.1007/s12275-022-00005-5
-
-
19
View
-
0
Download
-
5
Citations
-
Abstract
- With developments in synthetic biology, “engineering biology” has emerged through standardization and platformization
based on hierarchical, orthogonal, and modularized biological systems. Genome engineering is necessary to manufacture
and design synthetic cells with desired functions by using bioparts obtained from sequence databases. Among various tools,
the CRISPR-Cas system is modularly composed of guide RNA and Cas nuclease; therefore, it is convenient for editing
the genome freely. Recently, various strategies have been developed to accurately edit the genome at a single nucleotide
level. Furthermore, CRISPR-Cas technology has been extended to molecular diagnostics for nucleic acids and detection of
pathogens, including disease-causing viruses. Moreover, CRISPR technology, which can precisely control the expression
of specific genes in cells, is evolving to find the target of metabolic biotechnology. In this review, we summarize the status
of various CRISPR technologies that can be applied to synthetic biology and discuss the development of synthetic biology
combined with CRISPR technology in microbiology.
Journal Articles
- [Protocol] Development of DNA aptamers specific for small therapeutic peptides using a modified SELEX method
-
Jaemin Lee , Minkyung Ryu , Dayeong Bae , Hong-Man Kim , Seong-il Eyun , Jeehyeon Bae , Kangseok Lee
-
J. Microbiol. 2022;60(7):659-667. Published online June 22, 2022
-
DOI: https://doi.org/10.1007/s12275-022-2235-4
-
-
20
View
-
0
Download
-
4
Citations
-
Abstract
- Aptamers are short single-stranded DNA or RNA oligonucleotides
capable of binding with high affinity and specificity
to target molecules. Because of their durability and ease of synthesis,
aptamers are used in a wide range of biomedical fields,
including the diagnosis of diseases and targeted delivery of
therapeutic agents. The aptamers were selected using a process
called systematic evolution of ligands by exponential enrichment
(SELEX), which has been improved for various research
purposes since its development in 1990. In this protocol,
we describe a modified SELEX method that rapidly produces
high aptamer screening yields using two types of magnetic
beads. Using this method, we isolated an aptamer that
specifically binds to an antimicrobial peptide. We suggest that
by conjugating a small therapeutic-specific aptamer to a gold
nanoparticle-based delivery system, which enhances the stability
and intracellular delivery of peptides, aptamers selected
by our method can be used for the development of therapeutic
agents utilizing small therapeutic peptides.
- The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo
-
Kyungseob Noh , Eun Ju Jeong , Timothy An , Jin Soo Shin , Hyejin Kim , Soo Bong Han , Meehyein Kim
-
J. Microbiol. 2022;60(5):550-559. Published online April 18, 2022
-
DOI: https://doi.org/10.1007/s12275-022-1661-7
-
-
18
View
-
0
Download
-
4
Citations
-
Abstract
- Adjuvants are substances added to vaccines to enhance antigen-
specific immune responses or to protect antigens from
rapid elimination. As pattern recognition receptors, Toll-like
receptors 7 (TLR7) and 8 (TLR8) activate the innate immune
system by sensing endosomal single-stranded RNA of RNA
viruses. Here, we investigated if a 2,4-diaminoquinazolinebased
TLR7/8 agonist, (S)-3-((2-amino-8-fluoroquinazolin-
4-yl)amino)hexan-1-ol (named compound 31), could be used
as an adjuvant to enhance the serological and mucosal immunity
of an inactivated influenza A virus vaccine. The compound induced
the production of proinflammatory cytokines in macrophages.
In a dose-response analysis, intranasal administration
of 1 μg compound 31 together with an inactivated vaccine
(0.5 μg) to mice not only enhanced virus-specific IgG and
IgA production but also neutralized influenza A virus with
statistical significance. Notably, in a virus-challenge model,
the combination of the vaccine and compound 31 alleviated
viral infection-mediated loss of body weight and increased
survival rates by 40% compared with vaccine only-treated mice.
We suggest that compound 31 is a promising lead compound
for developing mucosal vaccine adjuvants to protect against
respiratory RNA viruses such as influenza viruses and potentially
coronaviruses.
TOP